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Recurrent miscarriage (RM) occurs in 1–3% of couples aiming at childbirth. Due tomultifac-
torial etiology the clinical diagnosis of RM varies.The design of genetic/“omics” studies to
identify genes and biological mechanisms involved in pathogenesis of RM has challenges
as there are several options in deﬁning the study subjects (female patient and/or couple
with miscarriages, fetus/placenta) and controls. An ideal study would attempt a trio-design
focusing on both partners as well as pregnancies of the couple. Application of genetic
association studies focusing on pre-selected candidate genes with potential pathologi-
cal effect in RM show limitations. Polymorphisms in ∼100 genes have been investigated
and association with RM is often inconclusive or negative. Also, implication of prognostic
molecular diagnostic tests in clinical practice exhibits uncertainties. Future directions in
investigating biomolecular risk factors for RM rely on integrating alternative approaches
(SNPs, copy number variations, gene/protein expression, epigenetic regulation) in studies
of single genes aswell as whole-genome analysis.This would be enhanced by collaborative
network between research centers and RM clinics.
Keywords: recurrent miscarriage, genetics, epigenetics, study design, research and clinical collaboration, associa-
tion studies, omic’s studies, placenta
INTRODUCTION
The occurrence of recurrent miscarriage (RM) has been estimated
1–3%of couples attempting to bear children (Berry et al., 1995;Rai
and Regan, 2006; Branch et al., 2010). While fetal chromosomal
abnormalities are responsible for 70% of sporadic miscarriages
(Ogasawara et al., 2000; Philipp et al., 2003; Menasha et al., 2005),
they account for considerably smaller fraction of pregnancy losses
in RM couples. Today, clinical practice includes testing of several
factors potentially increasing the risk of (recurrent) miscarriage,
e.g., parental chromosomal anomalies, maternal thrombophilic,
anatomic, endocrine, and immunological disorders (Bricker and
Farquharson, 2002; Christiansen et al., 2008; Branch et al., 2010;
Tang and Quenby, 2010). At least 50% of the RM cases have no
deviations in any applied diagnostic test and are considered idio-
pathic, unexplained origin. In addition to clinical, environmental,
and life-style risk factors, there is a growing evidence that RM
has also genetic susceptibility. A review of initial observations
indicated two to sevenfold increased prevalence of RM among
ﬁrst-degree blood relatives compared to the background pop-
ulation (Christiansen, 1996). Population-based register studies
showed that overall frequency of miscarriage among the siblings
of idiopathic RM is approximately doubled compared to gen-
eral population (Nybo Andersen et al., 2000; Kolte et al., 2011).
A recent genome-wide linkage scan using sibling pairs with idio-
pathicRMconﬁrmedheterogeneity of contributing genetic factors
(Kolte et al., 2011).
Unexplained RM is a stressful condition for a couple and sup-
portive care is currently the only assistance that can be offered.
Still, early recognition of a potential risk to miscarriage and
systematic monitoring has beneﬁcial effect in increasing live
birth rates in RM couples (Jauniaux et al., 2006; Branch et al.,
2010; Tang and Quenby, 2010; Musters et al., 2011). Genetic
and genomic studies of RM have three main purposes: (1) iden-
tify DNA/RNA-based markers exhibiting direct predictive value
to a couple’s risk to experience recurrent pregnancy losses; (2)
capture the gene/protein expression proﬁles, pathways, and net-
works involved in (un)successful establishment of pregnancy; (3)
apply hypothesis-based and hypothesis-free studies to pinpoint
loci coding for novel non-invasive biomarkers applicable in clinical
conditions for early pregnancy complications.
CHALLENGES IN STUDY DESIGN TO INVESTIGATE GENETICS
AND “OMICS” OF RM
The design of genetic/“omics” studies to identify genes and bio-
logical mechanisms involved pathogenesis of RM is complex
having several contradictory aspects regarding to the deﬁnition
of phenotype, study objects, and functional effects to address
(Figure 1).
DISCREPANCIES IN DEFINITION OF THE RM PHENOTYPE
Recurrent miscarriage is classically deﬁned as the loss of three
or more consecutive pregnancies before 20th gestational weeks
(Berry et al., 1995; Jauniaux et al., 2006; Branch et al., 2010). Some
experts consider two consecutive pregnancy losses sufﬁcient for
the diagnosis of RM because the recurrence rate and risk factors
are similar to that after three losses (Branch et al., 2010). The faulty
recall of the reproductive history, including or excluding the bio-
chemical pregnancies (pregnancies documented only by a positive
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FIGURE 1 |Two broad options to investigate the inheritable
component of recurrent miscarriage (RM) are family based linkage
studies and comparison of unrelated cases and controls. For
multifactorial diseases in adulthood the genetic association studies are
superior compared to linkage analysis in pedigrees in terms of study
design and power (Risch and Merikangas, 1996). In case of RM studies
the addressed subjects/biological materials represent genetic material
from two generations: mother–father and offspring(s), both providing
own advantages and limitations. The affected processes are located in
different compartments (mother–placenta–fetus) and involve aberrations
in gene/protein expression inﬂuencing both maternal and fetal
organisms.
urine or serum hCG test) and center-speciﬁc ascertainment biases
cause discrepancies in setting the diagnosis of RM (Christiansen
et al., 2005).
The couples with RM can be divided into subgroups according
to their reproductive history: primary (no successful pregnan-
cies), secondary (series of miscarriages after a live birth) and
tertiary (three non-consecutive miscarriages) RM and they should
be considered as separate entities representing probably differ-
ent pathophysiological mechanisms leading to pregnancy loss.
Immunological factors have been suggested to play a greater role
secondary RM, especially after the ﬁrst-born son (Christiansen
et al., 2004; Nielsen, 2011). Non-immunological risk factors, e.g.,
factor V Leiden mutation, tend to be associated mainly with
primary RM (Wramsby et al., 2000).
The analysis power of genetics/“omics” research depends on
the quality of the clinical history and applied diagnostic tests.
Currently, the cases of idiopathic RM have been considered as pre-
ferred phenotype for the genetics research.However, the deﬁnition
of idiopathic RM based on exclusions of known risk RM factors is
facilities- and study-dependent. The association and/or causality
of an etiologic factor with RM varies from“doubtful” to “deﬁnite”
complicating the deﬁnition of idiopathic RM (Christiansen et al.,
2005).
In summary, as RM is characterized by multifactorial etiology
and variable penetrance and clinical outcome of recognized risk
factors, a consensus in the clinical and research community has to
be reached what factors should be tested before deﬁning a partic-
ular case as idiopathic addressed via genetic/genomic studies.
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OPTIONS FOR DEFINING THE STUDY OBJECTS
One of the most challenging questions in investigating the
genetics of RM is deﬁning the study object(s): female patient
and/or couple with miscarriages, fetus, or placenta (Figure 1).
In genetic/genomic context these options target three different
genomes (mother, father, fetus/placenta) and four (epi)genomes
(different for placenta and fetus). In addition, as the deﬁnition of
RM is based on longitudinal data (several independent events),
one should remember that each pregnancy and each conceptus
is a unique genetic combination with unique epigenetic set-
tings, unique environmental conditions regarding the efﬁciency
of established maternal–fetal interphase, maternal nutrition, and
health.
Several genes that regulate implantation, fetal and placental
development, and maternal adaptation to pregnancy are synthe-
sized by the fetus or the placenta, e.g., placental hormones as
hCG,placental growthhormone and lactogen (Mannik et al., 2010;
Nagirnaja et al., 2010; Newbern and Freemark, 2011). In this con-
text, a placental (fetal) genome would represent an ideal RM case
for (epi)genetic and genomic studies. However, there are severe
limitations–the recruitment of couples/women at the RM event
and difﬁculties in obtaining pure tissue material from the aborted
fetus with no contamination with maternal cells. There are some
genetic studied focused on RM compared to control placentas
(e.g., HLA-C, HLA-G, p53, mtDNA mutations; Table 1) but the
sample sizes in these studies never reach required statistical power.
As a solution, an ideal study would attempt a trio-design focus-
ing on both partners of clinically well-described RM couples as
well as aborted cases and live born children (as inner control) of
the same couple. This would allow to directly address parental-
and allele-speciﬁc gene expression or epigenetic modiﬁcations in
placenta. The paternally inherited genetic factors contribute and
combine with maternally inherited factors in the placental/fetal
(epi)genome (Rull et al., 2008; Faridi and Agrawal, 2011; Uuskula
et al., 2011). So far, most studies of couples have been limited to
parental karyotyping, and in case of a structural chromosomal
abnormalities their effect on couple’s offsprings (Stephenson and
Sierra, 2006; Franssen et al., 2011).
The identiﬁcation of a suitable control group for
women/couples with RM has its own great challenges. The ideal
controls should be exposed to similar number of pregnancies
at the same age of partners as the cases, and never experienced
miscarriage. In a typical study the controls have been deﬁned
as women/couples with proven fertility when having at least
one child, with limited information about their full reproduc-
tive history during the present or past partnerships. Delaying the
childbirth until older reproductive age, the usage of contraceptive
methods after birth of the one or two planned children, the change
of co-habitant partners are frequent limitations for recruitment of
the ideal control group.
CHALLENGES IN LINKING THE GENETIC VARIANTS WITH THE
PATHOLOGICAL FUNCTIONAL EFFECT
A successful pregnancy can be achieved only via balanced dia-
log between mother and the fetus mediated through placenta.
The pathologies may locate and inﬂuence physiology in differ-
ent compartments (Figure 1). In maternal side, RM has been
associated with genes responsible for impaired endometrial decid-
ualization, apoptosis as well as inﬂammatory processes (Salker
et al., 2010).Multiple (epi)genetic/genomic factors decrease sperm
quality causingDNAdamage and thus leading topoor fertilization,
impaired embryo development and possibly to RM (McLachlan
and O’Bryan, 2010; Brahem et al., 2011). The development of
placenta and release of placentally expressed proteins strongly
inﬂuence both the fetal and maternal metabolism during the
pregnancy (Fowden et al., 2009; Lewis et al., 2012).
GENETIC ASSOCIATION STUDIES OF RM: BIASES,
CONTRADICTIONS, LIMITATIONS
All conducted genetic association studies targeting RM have been
designed as hypothesis-based candidate gene studies. The most
frequently addressed genes in the context of RM are associated
with the developing immunotolerance and inﬂammation and
also with changes of maternal metabolism and blood coagula-
tion (Table 1). Female partner of RM couple has been the most
commonly addressed study subject.
The polymorphisms in almost 90 different genes have been
investigated (Table 1). In most studies the association between
a polymorphism and RM is negative, has not been replicated
in follow-up studies or shows opposite results between studies.
Inconsistenciesmay arise due to (i) differences in studydesign,def-
initions of RMand control group; (ii) focus onRMwomen instead
of couples or placenta; (iii) low statistical power due to small
sample size; (iv) ethnic difference in risk variants, population-
speciﬁc low-impact gene variants increasing RM risk in consort ;
(v) contribution of life-style and environmental factors on the
pregnancy course; (vi) secondary pathways affecting protein trans-
lation/metabolism leading to discrepancies between genotype and
respective protein levels, e.g., Factor XII, Protein Z (Iinuma et al.,
2002; Topalidou et al., 2009).
Most popular clinically tested polymorphisms in RM patients
are thrombophilia-associated factor V (Leiden factor) mutation,
factor II (prothrombin) G20210A mutation and MTHFR C667T
variant encoding the methylenetetrahydrofolate reductase enzyme
with reduced activity. However, meta-analyses or large studies
focusing on these factors in relation to RM risk have controversial
results (Table 1). There is also uncertainty about prognostic impli-
cations of positive tests as full thrombophilia screen can produce
abnormal results in 20% of women with uncomplicated obstetric
histories (Branch et al., 2010; Tang and Quenby, 2010).
Another set of thoroughly investigated polymorphisms pro-
viding contradictory results in association with RM are in genes
involved in inﬂammation (e.g., IL1B, IL6, IL10, IFNγ, TNFα;
Table 1). The balance of locally produced pro-inﬂammatory
and anti-inﬂammatory cytokines was suggested to be critical
for successful pregnancy (Choi and Kwak-Kim, 2008). It was
proposed that a spectrum of thrombophilic and inﬂammation
related genetic variants rather than single polymorphisms shape
the cumulative risk of RM (Rey et al., 2003; Jivraj et al., 2006;
Christiansen et al., 2008).
The immunological mechanisms responsible for the devel-
opment of the tolerance to semi-allogeneic fetal “graft” by the
maternal immune system has been the third attractive target for
genetic studies. Positively, a majority of association studies with
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Table 1 | Genes targeted to genetic association studies in relation to RM risk.
Gene name Genetic associationa Main effect of the
polymorphismc
Key reference
Single
study
Meta-
analysis
Study
casesb
Mother Fetus/
placenta
INFLAMMATION
IFNG Y/N Y/N F Bombell and McGuire (2008), Daher et al. (2003)
IL1B Y/N Y/N F Bombell and McGuire (2008)
IL1RN Y/N F Choi and Kwak-Kim (2008)
IL1R1 N F Traina et al. (2011)
IL4 N F Kamali-Sarvestani et al. (2005), Saijo et al. (2004a)
IL6 Y/N Y/N F Bombell and McGuire (2008), Daher et al. (2003)
IL10 Y/N Y/N F Bombell and McGuire (2008), Daher et al. (2003)
IL12B N F Ostojic et al. (2007)
IL18 Y/N F Al-Khateeb et al. (2011), Naeimi et al. (2006)
IL21 Y F Messaoudi et al. (2011)
TNFα Y/N N F Bombell and McGuire (2008), Daher et al. (2003)
TNFβ N F Kamali-Sarvestani et al. (2005), Prigoshin et al. (2004)
TNFR1 N F Yu et al. (2007)
THROMBOSIS AND CARDIOVASCULAR SYSTEM
ACE Y/N F Goodman et al. (2009b), Zhang et al. (2011)
ACHE Y F Parveen et al. (2009b)
AGT N F Goodman et al. (2009b), Heﬂer et al. (2002)
ANXA5 Y F Bogdanova et al. (2007), Miyamura et al. (2011)
APOB N F, C Hohlagschwandtner et al. (2003), Yenicesu et al. (2009)
APOE Y/N F Bianca et al. (2010), Goodman et al. (2009a)
AT1R Y/N F Buchholz et al. (2004), Fatini et al. (2000)
EPCR Y/N F, C Dendana et al. (2012), Kaare et al. (2007)
F2 Y/N Y/N F, C Kovalevsky et al. (2004), Silver et al. (2010), Toth et al. (2008)
F5 Y/N Y/N F, C Dudding and Attia (2004), Kovalevsky et al. (2004), Rey et al. (2003),
Rodger et al. (2010), Toth et al. (2008)
FGB N F, C Goodman et al. (2006), Yenicesu et al. (2009)
F12 N N F Sotiriadis et al. (2007), Walch et al. (2005)
F13A Y/N N F, C Coulam et al. (2006a), Sotiriadis et al. (2007), Yenicesu et al. (2009)
GPIa Y F Gerhardt et al. (2005)
GPIIIa Y/N F, C Ivanov et al. (2010), Pihusch et al. (2001), Yenicesu et al. (2009)
HMOX1 Y F Denschlag et al. (2004)
JAK2 N F Dahabreh et al. (2009)
MTHFD1 N F Crisan et al. (2011)
MTHFR Y/N Y/N F, C Nelen et al. (2000), Ren andWang (2006), Toth et al. (2008)
PAI-1 Y/N N F Buchholz et al. (2003), Goodman et al. (2009b), Sotiriadis et al. (2007)
PZ Y/N F Dossenbach-Glaninger et al. (2008), Topalidou et al. (2009)
SELP Y F Dendana et al. (2011)
TAFI Y F Masini et al. (2009)
TGFB1 N F Prigoshin et al. (2004), von Linsingen et al. (2005)
TM N C Kaare et al. (2007)
TSER N F Kim et al. (2006a)
VEGF Y/N F Papazoglou et al. (2005), Traina et al. (2011)
ZPI Y F Alsheikh et al. (2012)
DETOXIFICATION SYSTEM
AHR N F Saijo et al. (2004b)
ARNT N F Sullivan et al. (2006)
CYP1A1 Y/N F Parveen et al. (2010), Saijo et al. (2004b)
CYP1A2 Y/N F Saijo et al. (2004b), Sata et al. (2005)
(Continued)
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Table 1 | Continued
Gene name Genetic associationa Main effect of the
polymorphismc
Key reference
Single
study
Meta-
analysis
Study
casesb
Mother Fetus/
placenta
CYP1B1 N F Saijo et al. (2004b)
CYP2D6 Y/N F Parveen et al. (2010), Suryanarayana et al. (2004)
GSTM1 Y/N F Parveen et al. (2010), Sata et al. (2003a)
GSTP1 Y/N F Parveen et al. (2010), Zusterzeel et al. (2000)
GSTT1 Y/N F Parveen et al. (2010), Sata et al. (2003a)
NAT2 N F Hirvonen et al. (1996)
CHROMOSOMAL SEGREGATION
SYCP3 Y/N F Bolor et al. (2009), Hanna et al. (2011), Mizutani et al. (2011)
IMMUNE RESPONSE
CCR5 Y/N F Parveen et al. (2009a, 2011b)
CTLA4 Y F, trio Tsai et al. (1998), Wang et al. (2005)
CX3CR1 Y F Parveen et al. (2011b)
HLA-A, B Y/N N C, trio Beydoun and Saftlas (2005), Christiansen et al. (1989), Kolte et al. (2010)
HLA-C Y/N N F, C, P Beydoun and Saftlas (2005), Faridi andAgrawal (2011), Hiby et al. (2010),
Moghraby et al. (2010)
HLA-E Y/N F, C Kanai et al. (2001), Mosaad et al. (2011), Steffensen et al. (1998)
HLA-G Y/N F, C, trio Aruna et al. (2010), Cecati et al. (2011), Hviid et al. (2004), Kolte et al.
(2010), Ober et al. (2003)
HLA-DPB1 Y C Takakuwa et al. (1999)
HLA-DQA1, HLA-DQB1 Y/N F, C, trio Aruna et al. (2011), Kruse et al. (2004), Steck et al. (1995)
HLA-DR ′ Y/N Y F, C, trio Beydoun and Saftlas (2005), Christiansen et al. (1999), Kolte et al.
(2010), Kruse et al. (2004)
INDO N F Amani et al. (2011)
KIR Y/N F, C Faridi et al. (2009), Hiby et al. (2008), Witt et al. (2004)
MBL N C Baxter et al. (2001)
HORMONAL REGULATION
AR (and XCI)d Y/N Y F Karvela et al. (2008b), Su et al. (2011a)
hCG beta (CGB5/8 ) Y C Rull et al. (2008)
CYP17A1 Y/N F Litridis et al. (2011), Sata et al. (2003b)
CYP19A1 Y F Cupisti et al. (2009), Suryanaryana et al. (2007)
PROGINS, ESR1/2 Y/N N F Su et al. (2011a), Traina et al. (2011)
PLACENTAL FUNCTION
ACP1 Y F ? ? Gloria-Bottini et al. (1996)
ADA Y F ? ? Nicotra et al. (1998)
ADRA2B N F Galazios et al. (2011)
ANGPT2 N F Pietrowski et al. (2003)
CD14 N F Karhukorpi et al. (2003)
EG-VEGF, PKR1, PKR2 Y F Su et al. (2010)
H19 N C Ostojic et al. (2008)
IGF-2 Y C Ostojic et al. (2008)
KDR Y F Su et al. (2011b)
MCP N F Heuser et al. (2011)
MMP9 N F Singh et al. (2012)
NOS3 Y/N F Karvela et al. (2008a), Parveen et al. (2011a)
P53 Y/N Y F, C, trio Coulam et al. (2006b), Kaare et al. (2009a), Pietrowski et al. (2005),
Tang et al. (2011)
PAPPA Y F Suzuki et al. (2006)
PGM1 Y C Bottini et al. (1983), Nicotra et al. (1982)
(Continued)
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Table 1 | Continued
Gene name Genetic associationa Main effect of the
polymorphismc
Key reference
Single
study
Meta-
analysis
Study
casesb
Mother Fetus/
placenta
STAT3 Y F Finan et al. (2010)
TPH1 N F Unfried et al. (2001)
MITOCHONDRIAL FUNCTION
Mutational burden Y/N F, C, trio Kaare et al. (2009b), Seyedhassani et al. (2010),Vanniarajan et al. (2011)
aY, positive association studies; N, negative studies.
bF, female RM patients; C, RM couple; P, placenta; trio, parents+ fetus/placenta.
cFunctional effect coded by maternal genome (e.g., expression in endometrium) or by fetal/placental genome is shown with ; ? speciﬁc localization of the effect not
clearly determined.
dSkewed X-chromosome inactivation (XCI) test is can be used to indirectly determine the association between androgen receptor (AR) CAG repeat expansion and
RM (Su et al., 2011a).
ACE, angiotensin I converting enzyme 1; ACHE, acetylcholinesterase; ACP1, acid phosphatase 1; ADA, adenosine deaminase; ADRA2B, adrenergic, alpha-2B-, recep-
tor; AGT, angiotensinogen; AHR, aryl hydrocarbon receptor; ANGPT2, angiopoietin 2; ANXA5, annexin A5; APOB, apolipoprotein B; APOE, apolipoprotein E; AR,
androgen receptor; ARNT, aryl hydrocarbon receptor nuclear translocator; AT1R, angiotensin II type-1 receptor; CCR5, chemokine receptor 5; CD14, CD14 molecule;
CGB5, chorionic gonadotropin, beta polypeptide 5; CGB8, chorionic gonadotropin, beta polypeptide 8; CTLA4, cytotoxic T-lymphocyte-associated protein 4; CX3CR1,
chemokine (C-X3-C motif) receptor 1; CYP1A1, cytochrome P450, family 1, subfamily A, polypeptide 1; CYP1A2, cytochrome P450, family 1, subfamily A, polypeptide
2; CYP1B1, cytochrome P450, family 1, subfamily B, polypeptide 1; CYP2D6, cytochrome P450, family 2, subfamily D, polypeptide 6; CYP17A1, cytochrome P450,
family 17, subfamily A, polypeptide 1; CYP19A1, cytochrome P450, family 19, subfamily A, polypeptide 1; EG-VEGF, endocrine-gland-derived vascular endothelial
growth factor; EPCR, endothelial protein C receptor; ESR1, estrogen receptor 1; ESR2, estrogen receptor 2; F2, coagulation factor II/prothrombin; F5, coagulation
factor V/factor V Leiden; F12, coagulation factor XII; F13A, coagulation factor XIII, A1 polypeptide; FGB, ﬁbrinogen beta chain; GPIa, platelet glycoprotein Ia; GPIIIa,
platelet glycoprotein IIIa; GSTM1, glutathione S-transferase mu 1; GSTP1, glutathione S-transferase pi 1; GSTT1, glutathione S-transferase theta 1; H19, imprinted
maternally expressed transcript (non-protein coding); HLA-A, major histocompatibility complex, class I, A; HLA-B, major histocompatibility complex, class I, B; HLA-C,
major histocompatibility complex, class I, C; HLA-E, major histocompatibility complex, class I, E; HLA-G, major histocompatibility complex, class I, G; HLA-DPB1, major
histocompatibility complex, class II, DP beta 1; HLA-DQA1, major histocompatibility complex, class II, DQ alpha 1; HLA-DQB1, major histocompatibility complex,
class II, DQ beta 1; HLA-DR′, major histocompatibility complex, class II, DR loci; HO-1, heme oxygenase 1; IFNG, interferon, gamma; IGF-2, insulin-like growth factor
2; IL1B, interleukin 1, beta; IL1RN, interleukin 1 receptor antagonist; IL1R1, interleukin 1 receptor, type I; IL4, interleukin 4; IL6, interleukin 6; IL10, interleukin 10;
IL12B, interleukin 12B; IL18, interleukin 18; IL21, interleukin 21; INDO, indole 2,3-dioxygenase; JAK2, Janus kinase 2; KDR, kinase insert domain receptor; KIR, killer
cell immunoglobulin-like receptor; MBL, mannose binding lectin; MCP, membrane cofactor protein; MMP9, matrix metallopeptidase 9; MTHFD1, methylenetetrahy-
drofolate dehydrogenase 1; MTHFR, methylenetetrahydrofolate reductase; NAT2, N-acetyltransferase 2; NOS3, nitric oxide synthase 3; P53, p53 tumor suppressor;
PAI-1, plasminogen activator inhibitor 1; PAPPA, pregnancy-associated plasma protein A; PGM1, phosphoglucomutase 1; PROGINS, progesterone receptor; PKR1,
prokineticin receptor 1; PKR2, prokineticin receptor 1; PZ, protein Z; SELP, selectin P; STAT3, signal transducer and activator of transcription 3; SYCP3, synaptonemal
complex protein 3;TAFI, thrombin-activatable ﬁbrinolysis inhibitor;TGFB1, transforming growth factor, beta 1;TM, thrombomodulin;TNFα, tumor necrosis factor-alpha;
TNFβ, tumor necrosis factor beta; TNFR1, tumor necrosis factor-alpha receptor 1; TSER, thymidylate synthetase enhancer region; TPH1, tryptophan hydroxylase 1;
VEGF, vascular endothelial growth factor A; ZPI, protein Z-dependent protease inhibitor.
immune response related genes have been conducted for RM cou-
ples (Table 1). Unfortunately, most reports on the studied gene
variants in relation to RM are controversial. There are numer-
ous studies on polymorphisms affecting the expression of HLA-G
(e.g., 14 bp indel in exon 8 of the 3′ UTR), the most dominant
HLA antigen in blastocysts and trophoblastic tissue. Recent analy-
ses have suggested that speciﬁc combinations of fetal (paternal)
HLA-C and maternal killer immunoglobulin-like receptor (KIR)
gene variants correlate with the risk to RM and other pregnancy
complications (Hiby et al., 2010; Chazara et al., 2011; Colucci et al.,
2011). KIRs regulate activity of uterineNK cells that are implicated
in trophoblast invasion.
During the last years the focus has gradually switched from
maternal factors to the genes involved in the function of pla-
centa, carrying maternally and paternally originated gene copies
(Table 1). The investigators have targeted placenta-speciﬁc genes
such as hCG beta coding CGB5 and CGB8, as well as loci with
wider expressional proﬁle but exhibiting a speciﬁc role in placental
function such as PAPPA, IGF-2, and p53 (Suzuki et al., 2006; Osto-
jic et al., 2008; Tang et al., 2011). Although initial genetic studies
have exhibited positive association between identiﬁed novel gene
variants and an increased risk to RM, replication studies have to
conﬁrm these ﬁndings.
ADVANCES AND FUTURE DIRECTIONS IN “OMICS” AND
(EPI)GENETICS
Genetic association studies based on pre-selected candidate genes
have shown their limitations as RM represents a complex pheno-
type with no identiﬁed major genetic factor(s). In order to achieve
the main goal – to identify predictive genetic risk factors and bio-
markers for RM, advances are needed in clinic as well as in the
research strategies.
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RECRUITMENT STRATEGY
Suggested advances in clinic include networking of research
groups aiming to collect large sample-sets targetingRMphenotype
under joint criteria and guidelines. Recruitment of both couples
suffering from RM as well as controls should be encouraged,
along with detailed clinical and reproductive history. Androl-
ogists are to be involved to analyze reproductive parameters
of male partners. Recruitment of duos (mother–placenta/fetus)
or trios (mother–father–placenta/fetus) would provide further
bonus. Studies should be enhanced by collecting the material for
DNA, RNA, and protein studies from the same recruited fam-
ily, e.g., parental blood samples, paternal sperm analysis, maternal
endometrial tissue, multisite placental tissue sampling. A network
of targeted clinics would facilitate carrying out validation of novel
identiﬁed biomarkers by setting up the large multicentre studies.
INTRODUCING “OMICS” INTO RM RESEARCH
With rapidly evolving technological advances in genetics/“omics”
there are multiple appealing perspectives in RM biomolecular
research (Figure 1).
Up to now, no hypothesis-free genome-wide association stud-
ies (GWAS) for identiﬁcation of common risk variants for RM
have been performed. The main reason is that large number of
uniformly deﬁned RM affected individuals/couples is required to
reach sufﬁcient power in such heterogenous phenotype (Eichler
et al., 2010). Copynumber variations (CNVs) involving one or sev-
eral loci are expected to exhibit a stronger effect on the phenotype
compared to SNPs. Comparative genome hybridization-based
microarray analysis of 26 euploidic miscarriages picked up 11
unique inherited CNVs, two of them involve genes TIMP2 (86 kb
duplication) and CTNNA3 (72 kb deletion) that are imprinted
and maternally expressed in the placenta (Rajcan-Separovic et al.,
2010). The ﬁrst results of ongoing study using genome-wide
genotyping data to map common CNVs demonstrated signiﬁ-
cantly more frequent prevalence of a 52.4-kb locus duplication
on chromosome 5 among RM couples in Estonian and Danish
population (Nagirnaja et al., 2011). These pilot studies alert for
further investigations of rare and common CNVs as risk factors
for RM.
Transcriptomics and proteomics based gene expression proﬁl-
ing in tissues responding to ongoing miscarriage event offers an
attractive approach to identify differentially expressed biomark-
ers (Baek et al., 2007). A decreased expression level in chorionic
villi from RM patients was shown for angiogenesis related loci,
whereas the expression of several apoptosis-related genes was
increased (Choi et al., 2003; Baek, 2004). The ﬁrst whole-genome
gene expression proﬁling of placental tissue from RM compared
to uncomplicated pregnancies identiﬁed and replicated signiﬁ-
cant differential expression of TNF-related apoptosis-inducing
ligand (TNFSF10;TRAIL) and S100A8 encoding for inﬂammatory
marker calprotectin (heterodimer S100A8/A9; Rull et al., 2012).
In comparative proteomics study applying 2-DE and MALDI-
TOF/MS analyses of the follicular ﬂuids of RM patients, abnormal
expression of complement component C3c chain E, ﬁbrinogen
γ, antithrombin, angiotensinogen, and hemopexin precursor was
reported (Kim et al., 2006b), and in the blood serum from RM
patients the expression of ITI-H4 was altered (Kim et al., 2011).
INTEGRATING OF GENETICS AND EPIGENETICS
An important factor of placental development and function is
epigenetic regulation governing the control of gene expression
(Nelissen et al., 2011). Epigenomic marks include CpG methyla-
tion in DNA, histone modiﬁcations in chromatin, and non-coding
regulatory RNAs. The speciﬁc features in placental epigenome are
(i) active temporal dynamics – changes in epigenetic marks over
course of pregnancy (Novakovic et al., 2011); (ii) complex orga-
nization of the DNA methylome and presence of tissue-speciﬁc
differentially methylated regions (Choufani et al., 2011; Chu et al.,
2011); (iii) abundance of parental-speciﬁc imprinted genes (Con-
stancia et al., 2004; Moore and Oakey, 2011); (iv) evidence of
polymorphic methylation or imprinting (Yuen et al., 2009); (v)
placenta-speciﬁc microRNAs (miRNAs; Luo et al., 2009; Maccani
and Marsit, 2009; Noguer-Dance et al., 2010); (vi) effect of envi-
ronmental factors, e.g., maternal smoking (Maccani et al., 2010).
Although altered placental epigenetics has been demonstrated in
cases of fetal growth disturbances, preeclampsia, and gestational
diabetes (Nelissen et al., 2011), there is limited information on the
role of aberrant epigenetic proﬁling inRM.Epigenetic comparison
of different cell types in early pregnancy is technically challenging.
The only systematically addressed topic is skewed X-chromosome
inactivation (XCI; the preferential inactivation of one of two X-
chromosomes in female cells). Initial ﬁndings that XCI is increased
in women with RM were promising (Sangha et al., 1999; Lanasa
and Hogge, 2000;Van denVeyver, 2001), but the follow-up studies
have revealed that the skewed XCI is associated rather with mater-
nal age and fetal karyotype than solely with RM (Hogge et al.,
2007; Pasquier et al., 2007; Warburton et al., 2009). Only single
studies are available for gene-speciﬁc methylation in RM-related
tissues (placenta, endometrium, maternal blood). For the biallel-
ically expressed hCG beta-subunit coding CGB5, three placentas
(including two RM) were reported with monoallelic expression of
maternal alleles and hemimethylated gene promoters suggesting
the association of methylation allelic polymorphism with preg-
nancy loss (Uuskula et al., 2011). Methyl transferase (G9aMT) and
methylated histone (H3-K9) expressions were signiﬁcantly lower
in decidual/endometrial tissue of unexplainedRMcases compared
to controls (Fatima et al., 2011). As a support to the contribu-
tion of epigenetic regulation of implantation, signiﬁcantly more
abnormal methylation values for APC and imprinted PEG3 were
reported in chorionic villus samples of abortions/stillbirth than in
other studied genes (Zechner et al., 2009).
No targeted microRNA expression proﬁling has been per-
formed for RM-related tissues. Still, there are placenta-speciﬁc
miRNAs capable of crossing the placental barrier and detectable
in maternal plasma (Chim et al., 2008; Miura et al., 2010) and an
altered proﬁle of several miRNAs has been shown in pregnancy
complications. Among the RM-associated genes, the expression
of HLA-G was shown to be modulated by a 3′ UTR polymor-
phism exhibiting allele-speciﬁc afﬁnity to microRNAs miR-148a,
miR-148b, and miR-152, and consequently differential mRNA
degradation and translation suppression processes (Tan et al.,
2007). A recent study showed association between two SNPs in
pre-miR-125a and increased risk to RM (Hu et al., 2011). As
miRNA expression data has been suggested to harbor potential in
discriminating disease samples with high accuracy (Scholer et al.,
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2011), there might be also strong perspectives in RM research and
potential clinical implications.
In conclusion, future directions in investigating biomolecu-
lar risk factors for RM rely on integrating alternative approaches
(DNA variants, gene and protein expression, epigenetic regula-
tion) in studies of individual genes as well as whole-genome
analysis. This would be greatly enhanced by extensive collaborative
network between research centers and RM clinics.
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